Chinese Medicine Group:Shugan Jieyu and Escitalopram placebo Oral
Sponsors
Shandong Mental Health Center
Conditions
Depression
Phase 4
Analysis of the efficacy and safety of SSRIs combined with Shugan Jieyu in the treatment of depression: a multicenter randomized, controlled, double-blind, prospective study
RecruitingITMCTR2100004545
Start: 2020-12-22Updated: 2023-02-20
Analysis of the efficacy and safety of SSRIs combined with Shugan Jieyu in the treatment of depression: a multicenter randomized, controlled, double-blind, prospective study
RecruitingChiCTR2000041328
Start: 2020-12-22Updated: 2021-03-08